Please wait, while we are loading the content...
Please wait, while we are loading the content...
| Content Provider | World Health Organization (WHO)-Global Index Medicus |
|---|---|
| Author | Obón-Santacana, Mireia Peeters, Petra H. M. Freisling, Heinz Dossus, Laure Clavel-Chapelon, Françoise Baglietto, Laura Schock, Helena Fortner, Renée T. Boeing, Heiner Tjønneland, Anne Olsen, Anja Overvad, Kim Menéndez, Virginia Sanchez, Maria-José Larrañaga, Nerea Huerta Castaño, José María Barricarte, Aurelio Khaw, Kay-Tee Wareham, Nick Travis, Ruth C. Merritt, Melissa A. Trichopoulou, Antonia Trichopoulos, Dimitrios Orfanos, Philippos Masala, Giovanna Sieri, Sabina Tumino, Rosario Vineis, Paolo Mattiello, Amalia Bueno-de-Mesquita, H. B. Onland-Moret, N. Charlotte Wirfält, Elisabeth Stocks, Tanja Idahl, Annika Lundin, Eva Skeie, Guri Gram, Inger T. Weiderpass, Elisabete Riboli, Elio Duell, Eric J. |
| Spatial Coverage | Europe |
| Description | Country affiliation: Spain Author Affiliation: Obón-Santacana M ( Unit of Nutrition, Environment, and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.); Peeters PH ( Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom. Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, the Netherlands.); Freisling H ( Dietary Exposure Assessment Group, International Agency for Research on Cancer, Lyon, France.); Dossus L ( Inserm, Centre for research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones, and Women's Health team, Villejuif, France. Univ Paris Sud, UMRS 1018, Villejuif, France. IGR, Villejuif, France.); Clavel-Chapelon F ( Inserm, Centre for research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones, and Women's Health team, Villejuif, France. Univ Paris Sud, UMRS 1018, Villejuif, France. IGR, Villejuif, France.); Baglietto L ( Cancer Epidemiology Centre, Cancer Council of Victoria, Melbourne, Australia. Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Australia.); Schock H ( Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.); Fortner RT ( Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.); Boeing H ( Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Nuthetal, Germany.); Tjønneland A ( Danish Cancer Society Research Center, Copenhagen, Denmark.); Olsen A ( Danish Cancer Society Research Center, Copenhagen, Denmark.); Overvad K ( Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark.); Menéndez V ( Public Health Directorate, Asturias, Spain.); Sanchez MJ ( Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria de Granada (Granada.ibs), Granada, Spain. Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública-CIBERESP), Madrid, Spain.); Larrañaga N ( Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública-CIBERESP), Madrid, Spain. Public Health Division of Gipuzkoa-BIODONOSTIA, Basque Regional Health Department, Spain.); Huerta Castaño JM ( Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública-CIBERESP), Madrid, Spain. Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain.); Barricarte A ( Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública-CIBERESP), Madrid, Spain. Navarre Public Health Institute, Pamplona, Spain.); Khaw KT ( University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.); Wareham N ( MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.); Travis RC ( Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.); Merritt MA ( Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.); Trichopoulou A ( Hellenic Health Foundation, Athens, Greece. Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece.); Trichopoulos D ( Hellenic Health Foundation, Athens, Greece. Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece. Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.); Orfanos P ( Hellenic Health Foundation, Athens, Greece. Department of Hygiene, Epidemiology, and Medical Statistics, University of Athens Medical School, Goudi, Athens, Greece.); Masala G ( Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy.); Sieri S ( Epidemiology and Prevention Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, Milano, Italy.); Tumino R ( Cancer Registry and Histopathology Unit, 'Civic - M.P. Arezzo' Hospital, ASP Ragusa, Italy.); Vineis P ( Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom. Human Genetics Foundation, Torino, Italy.); Mattiello A ( Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.); Bueno-de-Mesquita HB ( Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom. National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, the); Onland-Moret NC ( Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, the Netherlands.); Wirfält E ( Department of Clinical Sciences, Nutrition Epidemiology, Lund University, Malmö, Sweden.); Stocks T ( Department of Clinical Sciences, Nutrition Epidemiology, Lund University, Malmö, Sweden. Umeå University, Department of Perioperative and Surgical Sciences, Sweden.); Idahl A ( Department of Clinical Sciences, Obstetrics and Gynecology and Department of Public Health and Clinical Medicine, Nutritional Research, Umeå University, Umeå, Sweden.); Lundin E ( Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.); Skeie G ( Department of Community Medicine, Faculty of Health Sciences, UiT The Artic University of Norway, Tromsø, Norway.); Gram IT ( Department of Community Medicine, Faculty of Health Sciences, UiT The Artic University of Norway, Tromsø, Norway.); Weiderpass E ( Department of Community Medicine, Faculty of Health Sciences, UiT The Artic University of Norway, Tromsø, Norway. Cancer Registry of Norway, Oslo, Norway. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Department of Genetic Epidemiology, Folkhälsan Re); Riboli E ( Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.); Duell EJ ( Unit of Nutrition, Environment, and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain. eduell@iconcologia.net.) |
| Abstract | Acrylamide, classified in 1994 by the International Agency for Research on Cancer (IARC) as 'probably carcinogenic' to humans, was discovered in 2002 in some heat-treated, carbohydrate-rich foods. The association between dietary acrylamide intake and epithelial ovarian cancer risk (EOC) has been previously studied in one case-control and three prospective cohort studies which obtained inconsistent results and could not further examine histologic subtypes other than serous EOC. The present study was carried out in the European Prospective Investigation into Cancer and Nutrition (EPIC) subcohort of women (n = 325,006). Multivariate Cox proportional hazards models were used to assess the association between questionnaire-based acrylamide intake and EOC risk. Acrylamide was energy-adjusted using the residual method and was evaluated both as a continuous variable (per 10 µg/d) and in quintiles; when subgroups by histologic EOC subtypes were analyzed, acrylamide intake was evaluated in quartiles. During a mean follow-up of 11 years, 1,191 incident EOC cases were diagnosed. At baseline, the median acrylamide intake in EPIC was 21.3 µg/d. No associations and no evidence for a dose-response were observed between energy-adjusted acrylamide intake and EOC risk (HR10µg/d,1.02; 95% CI, 0.96-1.09; HRQ5vsQ1, 0.97; 95% CI, 0.76-1.23). No differences were seen when invasive EOC subtypes (582 serous, 118 endometrioid, and 79 mucinous tumors) were analyzed separately. This study did not provide evidence that acrylamide intake, based on food intake questionnaires, was associated with risk for EOC in EPIC. Additional studies with more reliable estimates of exposure based on biomarkers may be needed. |
| File Format | HTM / HTML |
| ISSN | 10559965 |
| e-ISSN | 15387755 |
| DOI | 10.1158/1055-9965.EPI-14-0636 |
| Journal | Cancer Epidemiology Biomarkers & Prevention |
| Issue Number | 1 |
| Volume Number | 24 |
| Language | English |
| Publisher | American Association for Cancer Research |
| Publisher Date | 2015-01-01 |
| Publisher Place | United States |
| Access Restriction | Open |
| Subject Keyword | Discipline Cancer epidemiology Acrylamide Adverse Effects Neoplasms, Glandular And Epithelial Etiology Ovarian Neoplasms Cohort Studies Nutrition Assessment Prospective Studies Risk Factors Multicenter Study Research Support, Non-u.s. Gov't |
| Content Type | Text |
| Resource Type | Article |
| Subject | Epidemiology Oncology |
National Digital Library of India (NDLI) is a virtual repository of learning resources which is not just a repository with search/browse facilities but provides a host of services for the learner community. It is sponsored and mentored by Ministry of Education, Government of India, through its National Mission on Education through Information and Communication Technology (NMEICT). Filtered and federated searching is employed to facilitate focused searching so that learners can find the right resource with least effort and in minimum time. NDLI provides user group-specific services such as Examination Preparatory for School and College students and job aspirants. Services for Researchers and general learners are also provided. NDLI is designed to hold content of any language and provides interface support for 10 most widely used Indian languages. It is built to provide support for all academic levels including researchers and life-long learners, all disciplines, all popular forms of access devices and differently-abled learners. It is designed to enable people to learn and prepare from best practices from all over the world and to facilitate researchers to perform inter-linked exploration from multiple sources. It is developed, operated and maintained from Indian Institute of Technology Kharagpur.
Learn more about this project from here.
NDLI is a conglomeration of freely available or institutionally contributed or donated or publisher managed contents. Almost all these contents are hosted and accessed from respective sources. The responsibility for authenticity, relevance, completeness, accuracy, reliability and suitability of these contents rests with the respective organization and NDLI has no responsibility or liability for these. Every effort is made to keep the NDLI portal up and running smoothly unless there are some unavoidable technical issues.
Ministry of Education, through its National Mission on Education through Information and Communication Technology (NMEICT), has sponsored and funded the National Digital Library of India (NDLI) project.
| Sl. | Authority | Responsibilities | Communication Details |
|---|---|---|---|
| 1 | Ministry of Education (GoI), Department of Higher Education |
Sanctioning Authority | https://www.education.gov.in/ict-initiatives |
| 2 | Indian Institute of Technology Kharagpur | Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project | https://www.iitkgp.ac.in |
| 3 | National Digital Library of India Office, Indian Institute of Technology Kharagpur | The administrative and infrastructural headquarters of the project | Dr. B. Sutradhar bsutra@ndl.gov.in |
| 4 | Project PI / Joint PI | Principal Investigator and Joint Principal Investigators of the project |
Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon |
| 5 | Website/Portal (Helpdesk) | Queries regarding NDLI and its services | support@ndl.gov.in |
| 6 | Contents and Copyright Issues | Queries related to content curation and copyright issues | content@ndl.gov.in |
| 7 | National Digital Library of India Club (NDLI Club) | Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach | clubsupport@ndl.gov.in |
| 8 | Digital Preservation Centre (DPC) | Assistance with digitizing and archiving copyright-free printed books | dpc@ndl.gov.in |
| 9 | IDR Setup or Support | Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops | idr@ndl.gov.in |
|
Loading...
|